Akèy › Skizofreni › Texas
Etid klinik pou Skizofreni nan Texas
34 etid pou Skizofreni ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Haracec Clinical Research, El Paso
- C-Trilogy Outreach, Longview
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Community Clinical Research, Inc., Austin
- Pillar Clinical Research, LLC, Richardson
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 28, 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0049, Austin
- Local Institution - 0194, Dallas
- Pillar Clinical Research - Richardson, Richardson
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Austin
- Neurocrine Clinical Site, DeSoto
- Neurocrine Clinical Site, Houston
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Texas Research Group, Coppell
- PsyMed Solutions, Fort Worth
- Kaleidoscope Clinical Research, Houston
- ak 3 plis
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT06229210Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, DeSoto
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227818Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- TG Therapeutics Investigational Trial Site, Richardson
Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Sep 23, 2026 · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
- Adams Clinical Dallas, DeSoto
- Re:Cognition Health - Fort Worth, Fort Worth
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Sep 22, 2026 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0149, Dallas
- VAST Clinical Research, Garland
- Local Institution - 0169, Houston
- ak 2 plis
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT07424404A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Austin
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Pillar Clinical Research, LLC, Richardson
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 17, 2026 · NCT07734493Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
- The University of Texas Health Science Center, Houston, Houston
Ap rekrite
Laj 22 a 65 · Tout sèks · Mizajou Sep 16, 2026 · NCT05276050A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Community Clinical Research - Cross Park Drive /ID# 272977, Austin
- Pillar Clinical Research - Richardson /ID# 275715, Richardson
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 15, 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- Adams Clinical, DeSoto
- Pillar Clinical Research, Richardson
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- VAST Clinical Research, Garland
- Local Institution - 0120, Houston
- Local Institution - 0066, Spring
Ap rekriteFaz 3
Laj 13 a 17 · Tout sèks · Mizajou Sep 4, 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Community Clinical Research, Austin
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 2, 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Austin
- Clinical Site, DeSoto
- Clinical Site, Richardson
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0016, Austin
- Local Institution - 0050, Dallas
- Local Institution - 0021, Fort Worth
- ak 10 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07379827Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- BioXcel Clinical Research Site, DeSoto
Ap rekriteFaz 1
Laj 10 a 17 · Tout sèks · Mizajou Aug 11, 2026 · NCT05025605Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
- The University of Texas Health Science Center at Houston, Houston
Ap rekrite
Laj 18 a 60 · Tout sèks · Mizajou Aug 5, 2026 · NCT07060066Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment
- The University of Texas Health Science Center at Houston, Houston
Ap rekrite
Laj 18 a 50 · Tout sèks · Mizajou Aug 3, 2026 · NCT02916810Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)
- The University of Texas Health Science Center, Houston, Houston
Ap rekrite
Laj 18 a 60 · Tout sèks · Mizajou Jul 7, 2026 · NCT06961916Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
- The University of Texas Health Science Center, Houston, Houston
Ap rekrite
Laj 18 a 60 · Tout sèks · Mizajou Jul 7, 2026 · NCT06345963A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Community Clinical Research, Austin
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Jun 23, 2026 · NCT07191483Deep Brain Stimulation for Psychosis
- UT Southwestern Medical Center, Dallas
Ap rekrite
Laj 22 a 70 · Tout sèks · Mizajou Jun 9, 2026 · NCT06257056A Study to Evaluate the Effect of KarXT on Urological Safety
- Local Institution - 0001, Austin
- InSite Clinical Research, DeSoto
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jun 3, 2026 · NCT07221877CLOZAPINE Response in Biotype-1
- UT Southwestern Medical Center, Dallas
Ap rekriteFaz 4
Laj 18 a 60 · Tout sèks · Mizajou May 11, 2026 · NCT04580134Database Registry for Neural Network Biomarkers in Psychosis
- University of Texas Southwestern Medical Center, Dallas
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Apr 23, 2026 · NCT01409109Ocrelizumab for Psychosis by Autoimmunity
- Houston Methodist Research Institute, Houston
Ap rekriteFaz 1/2
Laj 18 a 35 · Tout sèks · Mizajou Apr 1, 2026 · NCT03971487Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Texas Southwestern Medical Center, Dallas
Ap rekriteEtid obsèvasyon
Laj 18 a 40 · Tout sèks · Mizajou Mar 10, 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Austin
- Neurocrine Clinical Site, DeSoto
- Neurocrine Clinical Site, Houston
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Mar 6, 2026 · NCT06963034Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
- University of Texas at Dallas, Dallas
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2026 · NCT07098169Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Austin
- Vanda Investigational Site, Houston
- Vanda Investigational Site, Irving
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jan 12, 2026 · NCT06961968Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Austin
- Reviva site, Richardson
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Dec 19, 2024 · NCT05184335Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.